Congress will soon begin its annual process to set funding levels for government programs for fiscal year 2021 (FY21) and they need to hear from YOU about why funding breast cancer research, detection and treatment is important.
By increasing funding for breast cancer programs at the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH) and Department of Defense (DOD), we can end deaths from breast cancer once and for all. We know that cancer hasn’t stopped during the COVID-19 emergency and that means our advocacy must continue, too. We need three actions from Congress in the FY21 budget:
- Preserve women’s access to breast cancer screening and diagnostic services by funding the National Breast and Cervical Cancer Early Detection Program at $275 million;
- Biomedical research must remain an unwavering national priority by funding the National Institutes of Health at $44.7 billion; and
- Innovative breast cancer research conducted at the Department of Defense should continue as a priority by funding the Breast Cancer Research Program at $160 million.
These programs are especially important now, when many people are facing financial insecurity and lost jobs and non-governmental investments in critical cancer research continue to decline due to the economic impact of the COVID-19 epidemic. Biomedical research not only defends Americans against cancer and other diseases, but also serves as one of our nation’s primary paths to innovation, global competitiveness and economic growth.
Please ask your lawmakers to increase funding for these life-saving programs!